| Titolo |
Pubblicato in |
Anno |
| Poliprotect vs omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions. A randomized, controlled trial |
THE AMERICAN JOURNAL OF GASTROENTEROLOGY |
2023 |
| Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment |
DIGESTIVE AND LIVER DISEASE |
2023 |
| Role of the Gut-Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Primary biliary cholangitis: perception and expectation of illness |
DIGESTIVE AND LIVER DISEASE |
2022 |
| Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells |
SCIENTIFIC REPORTS |
2021 |
| FXR modulators and cholestatic diseases |
RECENTI PROGRESSI IN MEDICINA |
2021 |
| Evidence-based management of primary liver cancers: cholangiocarcinoma |
RECENTI PROGRESSI IN MEDICINA |
2021 |
| An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs |
JOURNAL OF HEPATOLOGY |
2021 |
| Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) |
JOURNAL OF TRANSLATIONAL MEDICINE |
2021 |
| Italian clinical practice guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging |
DIGESTIVE AND LIVER DISEASE |
2020 |
| DCLK1, a putative novel stem cell marker in human cholangiocarcinoma |
HEPATOLOGY |
2020 |
| Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment |
DIGESTIVE AND LIVER DISEASE |
2020 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
JOURNAL OF TRANSLATIONAL MEDICINE |
2020 |
| The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma |
PLOS ONE |
2019 |
| Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma |
ONCOTARGET |
2019 |
| Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023)) |
IMMUNITY |
2019 |
| The spanish influenza pandemic: a lesson from history 100 years after 1918 |
JOURNAL OF PREVENTIVE MEDICINE AND HYGIENE |
2019 |
| De morbo gallico omnia quae extant apud omnes medicos cuiuscunque nationis: the sixteenth-century collection of Luigi Luigini |
LE INFEZIONI IN MEDICINA |
2019 |
| New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin |
ANNALS OF GASTROENTEROLOGY |
2018 |
| The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma |
CELL REPORTS |
2018 |
